| Authors: |
Natsume-Kitatani Y; Laboratory of Bioinformatics, Artificial Intelligence Center for Health and Biomedical Research, National Institutes of Biomedical Innovation, Health and Nutrition (NIBN), Settsu, Osaka 566-0002, Japan; Institute of Advanced Medical Sciences, Tokushima University, Tokushima, Tokushima 770-8503, Japan; Institute for Protein Research, the University of Osaka, Suita, Osaka 565-0871, Japan., Kobiyama K; Laboratory of Vaccine Science, the Institute of Medical Science, the University of Tokyo (IMSUT), Minato-ku, Tokyo 108-8639, Japan; International Vaccine Design Center (VDesC), the Institute of Medical Science, the University of Tokyo (IMSUT), Minato-ku, Tokyo 108-8639, Japan; Division of Rheumatology, Department of Medicine, University of California, San Diego, La Jolla, CA 92093-0809, USA., Igarashi Y; Toxicogenomics-Informatics Project, Artificial Intelligence Center for Health and Biomedical Research, National Institutes of Biomedical Innovation, Health and Nutrition (NIBN), Settsu, Osaka 567-0085, Japan., Aoshi T; Department of Immunology, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8523, Japan., Nakatsu N; Toxicogenomics-Informatics Project, Artificial Intelligence Center for Health and Biomedical Research, National Institutes of Biomedical Innovation, Health and Nutrition (NIBN), Settsu, Osaka 567-0085, Japan., Tripathi LP; Laboratory of Bioinformatics, Artificial Intelligence Center for Health and Biomedical Research, National Institutes of Biomedical Innovation, Health and Nutrition (NIBN), Settsu, Osaka 566-0002, Japan; RIKEN Center for Integrative Medical Sciences, Yokohama, Kanagawa 230-0045, Japan., Ito J; Discovery Concept Validation Function, Eisai Co., Ltd., Kobe, Hyogo 650-0047, Japan., Nyström-Persson J; JNP Solutions, Sumida-ku, Tokyo 130-0015, Japan., Kosugi Y; Lifematics Ltd., Chuo-ku, Tokyo 104-0032, Japan., Allendes Osorio RS; Premium Research Institute for Human Metaverse Medicine (WPI-PRIMe), the University of Osaka, Suita, Osaka 565-0871, Japan., Nagao C; Institute for Protein Research, the University of Osaka, Suita, Osaka 565-0871, Japan., Temizoz B; Laboratory of Vaccine Science, the Institute of Medical Science, the University of Tokyo (IMSUT), Minato-ku, Tokyo 108-8639, Japan., Kuroda E; Department of Immunology, Hyogo Medical University School of Medicine, Nishinomiya, Hyogo 663-8501, Japan., Standley DM; Department of Genome Informatics, Genome Information Research Center, Research Institute for Microbial Diseases (RIMD), the University of Osaka, Suita, Osaka 565-0871, Japan., Kiyono H; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba 260-8670, Japan; Synergy Institute for Futuristic Mucosal Vaccine Research and Development (cSIMVa), Chiba University, Chiba, Chiba 260-8670, Japan; CU-UCSD Center for Mucosal Immunology, Allergy and Vaccines (cMAV), UC San Diego School of Medicine, San Diego, CA 92093-0063, USA., Nakanishi K; Department of Immunology, Hyogo Medical University School of Medicine, Nishinomiya, Hyogo 663-8501, Japan., Uematsu S; Department of Immunology and Genomics, Graduate School of Medicine, Osaka Metropolitan University, Abeno, Osaka 545-0051, Japan; Division of Metagenome Medicine, Human Genome Center, the Institute of Medical Science, the University of Tokyo, Minato-ku, Tokyo 108-8639, Japan., Hamaguchi I; Research Center for Biological Products in the Next Generation, National Institute of Infectious Diseases, Musashimurayama, Tokyo 208-0011, Japan., Yasutomi Y; Tsukuba Primate Research Center, National Institutes of Biomedical Innovation, Health and Nutrition (NIBN), Tsukuba, Ibaraki 305-0843, Japan., Kunisawa J; Laboratory of Vaccine Materials, Center for Vaccine and Adjuvant Research, National Institutes of Biomedical Innovation, Health and Nutrition (NIBN), Ibaraki, Osaka 567-0085, Japan., Yamasaki S; Department of Molecular Immunology, Research Institute for Microbial Diseases (RIMD), the University of Osaka, Suita, Osaka 565-0871, Japan; Laboratory of Molecular Immunology, Immunology Frontier Research Center (IFReC), the University of Osaka, Suita, Osaka 565-0871, Japan; Center for Infectious Disease Education and Research (CiDER), the University of Osaka, Suita, Osaka 565-0871, Japan; Center for Advanced Modalities and DDS (CAMaD), the University of Osaka, Suita, Osaka 565-0871, Japan., Coban C; International Vaccine Design Center (VDesC), the Institute of Medical Science, the University of Tokyo (IMSUT), Minato-ku, Tokyo 108-8639, Japan; Division of Malaria Immunology, Department of Microbiology and Immunology, The Institute of Medical Science (IMSUT), the University of Tokyo, Tokyo 108-8639, Japan; WPI Immunology Frontier Research Center (IFReC), the University of Osaka, Suita, Osaka 565-0871, Japan; The University of Tokyo Pandemic Preparedness, Infection and Advanced Research Center (UTOPIA), the University of Tokyo, Tokyo 108-8639, Japan., Yamada H; Toxicogenomics-Informatics Project, Artificial Intelligence Center for Health and Biomedical Research, National Institutes of Biomedical Innovation, Health and Nutrition (NIBN), Settsu, Osaka 567-0085, Japan., Mizuguchi K; Institute for Protein Research, the University of Osaka, Suita, Osaka 565-0871, Japan., Ishii KJ; Laboratory of Vaccine Science, the Institute of Medical Science, the University of Tokyo (IMSUT), Minato-ku, Tokyo 108-8639, Japan; International Vaccine Design Center (VDesC), the Institute of Medical Science, the University of Tokyo (IMSUT), Minato-ku, Tokyo 108-8639, Japan; WPI Immunology Frontier Research Center (IFReC), the University of Osaka, Suita, Osaka 565-0871, Japan; The University of Tokyo Pandemic Preparedness, Infection and Advanced Research Center (UTOPIA), the University of Tokyo, Tokyo 108-8639, Japan. Electronic address: kenishii@ims.u-tokyo.ac.jp. |
